Financial Information

08/07/2019 - 10:05 pm

DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy

08/01/2019 - 7:30 am | Half-year financial reports | Press releases

DBV Technologies Reports First Half 2019 Financial Results

08/01/2019 - 7:30 am | Half-year financial reports

Half-year financial report 2019

07/18/2019 - 7:30 am

Amendment to the DBV Technologies Liquidity Contract with NATIXIS ODDO BHF and Half-Year Report

07/12/2019 - 12:00 pm | Outstanding shares and voting rights statements

Monthly information regarding the total number of voting rights and total number of shares of the Company

08/01/2019 - 7:30 am | Finance

DBV Technologies Reports First Half 2019 Financial Results

08/01/2019 - 7:30 am | Finance

Half-year financial report 2019

05/13/2019 - 5:08 pm | General Assembly

Annual General Meeting, May 24, 2019

Statutory Auditors’ supplementary report on the share capital increase with cancellation of preferential subscription rights
Combined Shareholders’ Meeting of May 24, 2019
Download PDF (222 KB)

05/13/2019 - 5:02 pm | General Assembly

Annual General Meeting, May 24, 2019

Statutory Auditors’ report on the authorization to grant share subscription and/or share purchase options
Combined Shareholders’ Meeting of May 24, 2019 – 28th resolution
Download PDF (171 KB)

05/13/2019 - 5:00 pm | General Assembly

Annual General Meeting, May 24, 2019

Statutory Auditors’ report on the authorization to grant free shares (existing and/or to be issued) to employees and/or certain corporate officers
Combined Shareholders’ Meeting of May 24, 2019 – 27th resolution
Download PDF (191 KB)